Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors
- 10 February 2001
- journal article
- guideline
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 12 (3), 315-320
- https://doi.org/10.1089/10430340150218440
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Biosafety Monitoring of Patients Receiving Intracerebral Injections of Murine Retroviral Vector Producer CellsHuman Gene Therapy, 1998
- Evaluation of PCR and ELISA Assays for Screening Clinical Trial Subjects for Replication-Competent RetrovirusHuman Gene Therapy, 1997
- Evaluation of Recommendations for Replication-Competent Retrovirus Testing Associated with Use of Retroviral VectorsHuman Gene Therapy, 1997
- The Safety of Retroviral VectorsHuman Gene Therapy, 1993
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene.Molecular and Cellular Biology, 1985
- Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infectionVirology, 1982
- Rapid Cell Culture Assay Technique for Murine Leukaemia VirusesNature, 1971
- Plaque assay techniques for murine leukemia virusesVirology, 1970